BLOG

NK Cell Therapy in Japan: Regulation and Questions to Ask

Published 2026.10.15 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are researching NK cell therapy in Japan, you will quickly meet an unfamiliar phrase: the Act on the Safety of Regenerative Medicine. For international patients, it can be hard to tell what this law actually means for the treatment in front of you. This article explains, in plain terms, how cell therapies such as NK cell therapy are overseen in Japan and which questions are worth bringing to a consultation at Grand Green Osaka Umekita Clinic or any other provider.

Short answer: the law sets a framework, and your doctor explains the details

In Japan, NK cell therapy is offered as a private, self-funded treatment that is not covered by national health insurance. It is provided under a regenerative medicine framework, in which a clinic submits a treatment plan that is reviewed by a certified committee and then accepted by the Ministry of Health, Labour and Welfare. That framework is designed to add oversight, but it does not tell you whether a therapy will work for your situation. Whether NK cell therapy is appropriate for you, what it may cost, and what risks and side effects could apply must be confirmed in a medical consultation with a doctor.

What NK cell therapy involves

NK (natural killer) cells are a type of immune cell that circulates in the blood and can recognize and attack abnormal cells, including cancer cells and virus-infected cells. Research has also reported that NK cell activity may decline with age, stress and the effects of cancer itself. In NK cell therapy, a blood sample is taken, and your own NK cells are activated and expanded at a specialized cell processing facility. The expanded cells are then returned to your body by intravenous infusion.

Because the cells come from your own body, the risk of rejection is considered low. Even so, temporary reactions such as fever or fatigue can occur, and no treatment is free of risk. The aim of the therapy is to support immune function, and it is generally discussed as an option to consider alongside standard cancer treatment, not as a replacement for surgery, chemotherapy or radiation therapy.

How the regenerative medicine framework works in practice

Japan’s regenerative medicine law groups cell-based treatments by their level of risk and requires a clinic to follow a defined process before it can offer them. In broad terms, the process includes the following steps.

The clinic prepares a treatment plan describing the cells used, how they are processed and how patients are monitored.
A certified committee for regenerative medicine reviews the plan.
The plan is submitted to the health authorities, and treatment may begin only after it has been accepted.
Cell processing is carried out at a facility that is licensed or notified under the same system.
The clinic must report on treatment and on health problems that occur.

This structure is meant to improve transparency and quality control. It is not a stamp of approval for effectiveness. A therapy offered under this framework is different from a drug that has completed standard clinical trials and gained insurance coverage, and that is why careful explanation and informed consent matter so much.

Questions to ask about quality and safety

Before you decide, it can help to write down your questions and bring them to your appointment. Useful topics include the following.

Which treatment plan covers this therapy, and can I see the information that is publicly available about it?
Where are my cells processed, and how is quality checked before the cells are returned to me?
What is known, and what is not yet known, about benefits for my type and stage of cancer?
What temporary reactions or other risks could I experience, and what happens if they occur?
How would treatment be timed around my surgery, chemotherapy or radiation therapy, and can the clinic coordinate with my treating hospital?
What are the total costs, the number of treatments and the expected schedule, and are there any extra charges?

A trustworthy clinic should be comfortable answering these questions and should explain limits as clearly as potential benefits. Be cautious about any explanation that promises a particular result, that suggests you should stop standard treatment, or that relies on personal testimonials in place of medical evidence.

Understanding the evidence and its limits

Research on NK cell approaches, including laboratory studies and early clinical studies, is active, and published results are mixed and often limited by small numbers of participants or differences in study design. Findings in one cancer type cannot simply be applied to another. For this reason, it is wise to treat NK cell therapy as an option to discuss with your oncologist and with the clinic, not as a proven answer. You can look for peer-reviewed studies in public databases such as PubMed, and ask your doctor to explain how they relate to your own situation.

Practical points for patients visiting Osaka

Grand Green Osaka Umekita Clinic is located in Umeda, Osaka, and it provides information pages in several languages, including English, for international patients. If you are considering travel for treatment, plan time for an initial consultation, blood collection and later infusions, and ask about the schedule in advance. It is also sensible to ask your home doctor to share your medical records and to confirm how follow-up care will be handled after you return home.

Because NK cell therapy is a self-funded treatment in Japan, fees are not covered by national health insurance. Please check the clinic’s fees page and confirm all costs, risks and side effects directly with a doctor before agreeing to treatment.

Key takeaways

Japan’s regenerative medicine framework adds review and reporting requirements for cell therapies such as NK cell therapy, but it does not determine whether the treatment is right for you. The most useful step is a thorough consultation in which you ask about the treatment plan, cell processing, evidence, risks, scheduling with your standard treatment and total cost. If you would like to learn more, you can read the NK cell therapy information page in English and then talk with a doctor about your own circumstances.

Questions before NK cell therapy

Know the framework
Ask about cell processing
Check risks and evidence
Confirm total costs

This figure is a conceptual summary of the article content

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›